top of page
cells.gif

ICE-T Congress
'Immune Cellular Effector Therapies'

Innovation. Collaboration. Education

The Mission: Empowering Access to Revolutionary Cellular Therapies for All.

​

CAR-T (Chimeric Antigen T cell) and bispecific antibodies are changing the landscape of treatment for blood cancers and extending hope to those battling solid organ cancers and autoimmune diseases.

 

Sadly, only a small fraction of eligible patients can currently access these vital therapies .

 

With the ICE-T congress, we aim to foster a nurturing Academic-Community partnership, where we learn from and support each other, encouraging big dreams and breaking down barriers to care.

 

In Kansas City, KS, we began our journey in July 2024, and since then, we’ve hosted our first National ICE-T Congress in Orlando, FL, in July 2025. We are now proud to announce the second regional ICE-T Congress in Kansas City, KS, scheduled for September 2025.

 

We believe in advocating at all levels- even international- with plans for another congress outside the US on the horizon. Stay tuned!

 

Our mission is to stand up for every patient who has faced these barriers on their path to healing, advocating for their right to access ICE-T therapies. Together, we can inspire change and bring hope to those in need.

NEXT ICE-T Congress:
September 27-28, 2025
Kansas City, KS 

Wavy Abstract Background

Day 1- Sept 27
Highlights

Day 1- Sept 27 Workshops/Breakouts

Day 2- Sept 28
Highlights  

We feature interactive panels and talks on topics related to myeloma, whats on the horizon for CAR-T and ICE-T in solid tumors and autoimmune diseases

Day 2- Sept 28
Special 

We have curated a selection of workshops to fit your taste and desire. 

You can choose from:

​

- Hands-on management of toxicities with simulated cases. Literally hands-on!

​

- Building bispecific and cell therapy programs: What are the building blocks and roadblocks? Sharing experiences.

 

- Translational Research Highlights for our hardcore scientists.

Scholar Research 

We will discuss and debate on how ICE-T Therapies are shaping the lymphoma landscape, as well as emerging roles in leukemia. 

Networking, Awards, and Much More

We are honored to present to you our guest - Dr Syed Osman Ali Ahmed- from King Faisal Specialist Hospital & Research Center who will share the unique global experiences with implementing CAR-T and Bispecifics in Saudi Arabia. 

We have emerging scholars, in the field of nursing and medicine, who share clinical research and how it impacts patient care. 

Award ceremony at lunch hour. This is a special surprise. 

​

Networking, making new friends and enjoying coffee together is a goal. 

​

bottom of page